NCT02135848 - 3 Month PHI PAD PoM Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 15, 2010

Primary Completion Date

November 1, 2011

Study Completion Date

November 1, 2011

Conditions

Vascular Disease, Peripheral

Interventions

DRUG

GSK1278863

DRUG

Placebo

Trial Locations (12)

GSK Investigational Site, Philadelphia

GSK Investigational Site, Norfolk

GSK Investigational Site, Durham

GSK Investigational Site, Boone

GSK Investigational Site, Clearwater

GSK Investigational Site, Sarasota

GSK Investigational Site, Toledo

GSK Investigational Site, Indianapolis

GSK Investigational Site, Chicago

GSK Investigational Site, San Antonio

GSK Investigational Site, Vista

GSK Investigational Site, Palo Alto